Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2021	$ 9,387	$ 123,904,602	$ (60,703,562)	$ 63,210,427
Balance (in shares) at Dec. 31, 2021	28,448,612
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,128,973	0	1,128,973
Issuances of common stock, from exercise of stock options	$ 1	7,487	0	7,488
Issuances of common stock, from exercise of stock options (in shares)	2,282
Net loss	$ 0	0	(8,473,522)	(8,473,522)
Balance at Mar. 31, 2022	$ 9,388	125,041,062	(69,177,084)	55,873,366
Balance (in shares) at Mar. 31, 2022	28,450,894
Balance at Dec. 31, 2021	$ 9,387	123,904,602	(60,703,562)	63,210,427
Balance (in shares) at Dec. 31, 2021	28,448,612
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances of common stock from the Sales Agreement, net				$ 9,900,000
Issuances of common stock from the Sales Agreement, net (in shares)				1,238,491
Net loss				$ (40,854,855)
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Balance at Mar. 31, 2022	$ 9,388	125,041,062	(69,177,084)	55,873,366
Balance (in shares) at Mar. 31, 2022	28,450,894
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,348,601	0	1,348,601
Issuances of common stock, from exercise of stock options	$ 3	22,426	0	22,429
Issuances of common stock, from exercise of stock options (in shares)	7,794
Net loss	$ 0	0	(5,819,200)	(5,819,200)
Balance at Jun. 30, 2022	$ 9,391	126,412,089	(74,996,284)	51,425,196
Balance (in shares) at Jun. 30, 2022	28,458,688
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,344,349	0	1,344,349
Issuance of warrants		1,713,741	0	1,713,741
Net loss	0	0	(7,424,450)	(7,424,450)
Balance at Sep. 30, 2022	$ 9,391	129,470,179	(82,420,734)	47,058,836
Balance (in shares) at Sep. 30, 2022	28,458,688
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,374,233	0	1,374,233
Issuances of common stock, from exercise of stock options	$ 89	1,563,756	0	1,563,845
Issuances of common stock, from exercise of stock options (in shares)	269,535
Net shares for settlements of equity awards and taxes	$ (58)	(1,713,247)	0	(1,713,305)
Net shares for settlements of equity awards and taxes (in shares)	(175,184)
Issuance of common stock for consulting/licensing agreement	$ 125	4,999,863	0	4,999,988
Issuance of common stock for consulting/licensing agreement (in shares)	378,787
Issuances of common stock from the Sales Agreement, net	$ 409	9,855,707	0	9,856,116
Issuances of common stock from the Sales Agreement, net (in shares)	1,238,491
Net loss	$ 0	0	(19,137,683)	(19,137,683)
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,080,319	0	2,080,319
Issuances of common stock from the Sales Agreement, net	$ 183	4,588,339	0	4,588,522
Issuances of common stock from the Sales Agreement, net (in shares)	553,293
Net loss	$ 0	0	(9,659,918)	(9,659,918)
Balance at Mar. 31, 2023	$ 10,139	152,219,149	(111,218,335)	41,010,953
Balance (in shares) at Mar. 31, 2023	30,723,610
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for consulting/licensing agreement				5,000,000
Issuance of common stock for consulting/licensing agreement (in shares)	200,000
Issuances of common stock from the Sales Agreement, net				$ 16,100,000
Issuances of common stock from the Sales Agreement, net (in shares)				2,642,269
Net loss				$ (42,942,198)
Balance at Dec. 31, 2023	$ 10,921	170,620,641	(144,500,615)	26,130,947
Balance (in shares) at Dec. 31, 2023	33,094,521
Balance at Mar. 31, 2023	$ 10,139	152,219,149	(111,218,335)	41,010,953
Balance (in shares) at Mar. 31, 2023	30,723,610
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,105,538	0	2,105,538
Issuances of common stock, from exercise of stock options	$ 1	8,848	0	8,849
Issuances of common stock, from exercise of stock options (in shares)	1,409
Issuance of common stock for consulting/licensing agreement	$ 33	609,967	0	610,000
Issuance of common stock for consulting/licensing agreement (in shares)	100,000
Issuances of common stock from the Sales Agreement, net	$ 14	243,729	0	243,743
Issuances of common stock from the Sales Agreement, net (in shares)	43,169
Net loss	$ 0	0	(11,534,895)	(11,534,895)
Balance at Jun. 30, 2023	$ 10,187	155,187,231	(122,753,230)	32,444,188
Balance (in shares) at Jun. 30, 2023	30,868,188
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,073,607	0	2,073,607
Issuances of common stock from the Sales Agreement, net	$ 46	815,156	0	815,202
Issuances of common stock from the Sales Agreement, net (in shares)	139,575
Net loss	$ 0	0	(10,849,169)	(10,849,169)
Balance at Sep. 30, 2023	$ 10,233	158,075,994	(133,602,399)	24,483,828
Balance (in shares) at Sep. 30, 2023	31,007,763
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,354,857	0	1,354,857
Issuances of common stock, from exercise of stock options	$ 26	300,067	0	300,093
Issuances of common stock, from exercise of stock options (in shares)	80,526
Issuance of common stock for consulting/licensing agreement	$ 33	410,967	0	411,000
Issuance of common stock for consulting/licensing agreement (in shares)	100,000
Issuances of common stock from the Sales Agreement, net	$ 629	10,478,756	0	10,479,385
Issuances of common stock from the Sales Agreement, net (in shares)	1,906,232
Net loss	$ 0	0	(10,898,216)	(10,898,216)
Balance at Dec. 31, 2023	$ 10,921	$ 170,620,641	$ (144,500,615)	$ 26,130,947
Balance (in shares) at Dec. 31, 2023	33,094,521